Quiver Bioscience is building the world's leading human functional intelligence platform for CNS drug discovery and advancing an internal pipeline of precision therapeutics for neurological and pain disorders. The company's proprietary platform is anchored by the largest functional neuronal dataset comprised of over 1.5 billion action potentials across over 30 million individual neurons, 18,000 gene perturbations, and 3,500 drug fingerprints enabling precise target identification, functional validation, and safety assessment at unmatched scale. Quiver's integrated wetware, hardware, and AI software architecture operates as a self-reinforcing lab-in-the-loop, where every experiment improves the underlying models and every partnership deepens the platform's competitive advantage. The platform has been validated across several CNS programs and partnerships and has yielded multiple therapeutic candidates now advancing through IND-enabling development.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
04/13/26	undisclosed	Strategic	Porta	undisclosed